PubMed

High-priced technology can be good value for money.

Weinstein MC.

Ann Intern Med. 1999 May 18;130(10):857-8. No abstract available. PMID: 10366377 [PubMed - indexed for MEDLINE]Related articlesFree article

Low-molecular-weight heparin versus warfarin for secondary prophylaxis of venous thromboembolism: a cost-effectiveness analysis.

Marchetti M, Pistorio A, Barone M, Serafini S, Barosi G.

Am J Med. 2001 Aug;111(2):130-9.PMID: 11498067 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism.

Johnston JA, Brill-Edwards P, Ginsberg JS, Pauker SG, Eckman MH.

Am J Med. 2005 May;118(5):503-14. Review.PMID: 15866253 [PubMed - indexed for MEDLINE]Related articles

The cost-effectiveness of extended-duration antithrombotic prophylaxis after total hip arthroplasty.

Skedgel C, Goeree R, Pleasance S, Thompson K, O'brien B, Anderson D.

J Bone Joint Surg Am. 2007 Apr;89(4):819-28. Review.PMID: 17403806 [PubMed - indexed for MEDLINE]Related articles

Doing more with less.

Bryan-Brown CW, Dracup K.

Am J Crit Care. 1996 Sep;5(5):320-2. No abstract available. PMID: 8870853 [PubMed - indexed for MEDLINE]Related articles

Cost effectiveness of bemiparin sodium versus unfractionated heparin and oral anticoagulants in the acute and long-term treatment of deep vein thrombosis.

Gómez-Outes A, Rocha E, Martínez-González J, Kakkar VV.

Pharmacoeconomics. 2006;24(1):81-92.PMID: 16445305 [PubMed - indexed for MEDLINE]Related articles

Cost effectiveness of tinzaparin sodium versus unfractionated heparin in the treatment of proximal deep vein thrombosis.

Caro JJ, Getsios D, Caro I, O'Brien JA.

Pharmacoeconomics. 2002;20(9):593-602.PMID: 12141887 [PubMed - indexed for MEDLINE]Related articles

Echocardiography in patients with suspected endocarditis: a cost-effectiveness analysis.

Heidenreich PA, Masoudi FA, Maini B, Chou TM, Foster E, Schiller NB, Owens DK.

Am J Med. 1999 Sep;107(3):198-208.PMID: 10492311 [PubMed - indexed for MEDLINE]Related articles

Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis.

O'Brien B, Levine M, Willan A, Goeree R, Haley S, Blackhouse G, Gent M.

Arch Intern Med. 1999 Oct 25;159(19):2298-304.PMID: 10547169 [PubMed - indexed for MEDLINE]Related articlesFree article

Low-molecular-weight heparin in transesophageal echocardiography-guided cardioversion of atrial fibrillation.

Wodlinger AM, Pieper JA.

Pharmacotherapy. 2003 Jan;23(1):57-63. Review.PMID: 12523460 [PubMed - indexed for MEDLINE]Related articles

Potential clinical efficacy and cost benefit of a transesophageal echocardiography-guided low-molecular-weight heparin (enoxaparin) approach to antithrombotic therapy in patients undergoing immediate cardioversion from atrial fibrillation.

Murray RD, Deitcher SR, Shah A, Jasper SE, Bashir M, Grimm RA, Klein AL.

J Am Soc Echocardiogr. 2001 Mar;14(3):200-8.PMID: 11241016 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of low-molecular-weight heparin for treatment of pulmonary embolism.

Aujesky D, Smith KJ, Cornuz J, Roberts MS.

Chest. 2005 Sep;128(3):1601-10.PMID: 16162764 [PubMed - indexed for MEDLINE]Related articlesFree article

Safety of expedited anticoagulation in patients undergoing transesophageal echocardiographic-guided cardioversion.

Wu LA, Chandrasekaran K, Friedman PA, Ammash NM, Ramakrishna G, Hart CY, Moon BS, Herges RM, Rosales AG, Malouf JF.

Am J Med. 2006 Feb;119(2):142-6.PMID: 16443416 [PubMed - indexed for MEDLINE]Related articles

Cardioversion related thromboembolism: value of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.

Seidl K, Senges J.

Card Electrophysiol Rev. 2003 Dec;7(4):392-6. Review.PMID: 15071262 [PubMed - indexed for MEDLINE]Related articles

Cost effectiveness of adult intensive care in the UK.

Ridley S, Morris S.

Anaesthesia. 2007 Jun;62(6):547-54. Review.PMID: 17506731 [PubMed - indexed for MEDLINE]Related articles

Long-term cost-effectiveness of low molecular weight heparin versus unfractionated heparin for the prophylaxis of venous thromboembolism in elective hip replacement.

Marchetti M, Liberato NL, Ruperto N, Barosi G.

Haematologica. 1999 Aug;84(8):730-7.PMID: 10458700 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients.

Okwonna AC, Sansgiry SS.

Am J Manag Care. 2005 Mar;11(3):134. No abstract available. PMID: 15786848 [PubMed - indexed for MEDLINE]Related articlesFree article

A systematic review of economic analyses of low-molecular-weight heparin for the treatment of venous thromboembolism.

Sprague S, Cook DJ, Anderson D, O'Brien BJ.

Thromb Res. 2003;112(4):193-201. Review.PMID: 14987911 [PubMed - indexed for MEDLINE]Related articles

Use of low-molecular-weight heparin as bridge anticoagulation therapy in patients with atrial fibrillation undergoing transoesophageal echocardiography guided cardioversion.

Murray RD, Deitcher SR, Klein AL.

Eur Heart J. 2001 Apr;22(8):712-3. No abstract available. PMID: 11286529 [PubMed - indexed for MEDLINE]Related articles

Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitäts Trial (BASKET): an 18-month analysis.

Brunner-La Rocca HP, Kaiser C, Bernheim A, Zellweger MJ, Jeger R, Buser PT, Osswald S, Pfisterer M; BASKET Investigators.

Lancet. 2007 Nov 3;370(9598):1552-9.PMID: 17980734 [PubMed - indexed for MEDLINE]Related articles